Why is governance of addiction so difficult? What can we learn from recent experiences and efforts in Europe? Governance of Addictions analyses the multidisciplinary research which has been used as a framework for understanding how governments formulate and implement addiction policies in 27 European Union member states plus Norway, looking in detail at four substances: heroin, cannabis, alcohol and tobacco. Presenting the methodological design for the study research, this book comprehensively analysing international trends, with a special focus on the role of the EU and its governance of addictions modes, this volume sheds light on the current situation of the governance of addictive substances and behaviours and facilitate new approaches to dealing with addiction. Based on the research from ALICE RAP (Addiction and Lifestyles in Contemporary Europe, Reframing Addictions Project), a unique project studying the place of addictive substances and behaviours in contemporary European society, Governance of Addictions is essential reading for policy-makers, public managers, practitioner and stakeholders influencing policy for addictive substances and behaviours, as well as academics and public health professionals.

Presenting the findings of a five year project studying the pace and impact of addictions in Europe, this work deconstructs the failures and promises of European governance polices for reducing the harm done by legal and illegal drugs and posits a nine point plan as a way forward to redesign addictions governance

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.

An essential reference for psychiatrists, clinical psychologists, trainees, and specialist nurses, as well as primary care physicians/GPs with a special interest in mental health conditions and other healthcare professionals.

Analyses the impact of addictive drugs (alcohol, nicotine and illegal drugs) and behaviours (gambling) on the health and wellbeing of individuals and societies based on the latest research and within an innovative new conceptual framework

All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.

First-hand account of the current state of addiction governance in Europe, utilising a unique dataset of corporate memberships and networks across the EU to document the overall architecture of corporate political activity and the role addictive substance and behaviour-producing industries play in influencing addiction policy in Europe.